{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:31:02Z","timestamp":1770744662213,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.yebeh.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T14:45:15Z","timestamp":1505486715000},"page":"110-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study"],"prefix":"10.1016","volume":"76","author":[{"given":"Usha K.","family":"Misra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepanshu","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayantee","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2017.07.005_bb0005","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans affairs status epilepticus cooperative study group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl. 8","key":"10.1016\/j.yebeh.2017.07.005_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2011.03235.x","article-title":"RAMPART (rapid anticonvulsant medication prior to arrival trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics","volume":"52","author":"Silbergleit","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0020","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London colloquium on status epilepticus","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0025","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1528-1157.1998.tb01311.x","article-title":"Nonconvulsive status epilepticus in the critically ill elderly","volume":"39","author":"Litt","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-011-6227-2","article-title":"Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study","volume":"259","author":"Misra","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1756285608100460","article-title":"New treatment options in status epilepticus: a critical review on intravenous levetiracetam","volume":"2","author":"Trinka","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.seizure.2009.11.007","article-title":"Management of refractory status epilepticus at a tertiary care centre in a developing country","volume":"19","author":"Tripathi","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1528-1167.2007.01317.x","article-title":"Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures","volume":"49","author":"Biton","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0060","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1528-1167.2009.02463.x","article-title":"Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures","volume":"51","author":"Krauss","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14737175.9.1.33","article-title":"Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures","volume":"9","author":"Beydoun","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"H\u00f6fler","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1756285611403826","article-title":"Nonconvulsive status epilepticus: a diagnostic and therapeutic challenge in the intensive care setting","volume":"4","author":"Holtkamp","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0085","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy","volume":"255","author":"Rossetti","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.seizure.2004.06.001","article-title":"Estimating the economic burden of status epilepticus to the health care system","volume":"14","author":"Penberthy","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/trstmh\/tru008","article-title":"Spectrum and outcome predictors of central nervous system infections in a neurological critical care unit in India: a retrospective review","volume":"108","author":"Misra","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0100","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1111\/j.1528-1167.2011.03204.x","article-title":"Intravenous lacosamide in status epilepticus and seizure clusters","volume":"52","author":"H\u00f6fler","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.yebeh.2008.12.009","article-title":"Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy","volume":"14","author":"Kellinghaus","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1528-1167.2009.02256.x","article-title":"Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide","volume":"51","author":"Tilz","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2010.01423.x","article-title":"Intravenous lacosamide for treatment of status epilepticus","volume":"123","author":"Kellinghaus","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yebeh.2010.10.012","article-title":"Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients","volume":"20","author":"Parkerson","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.2010.01430.x","article-title":"Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus","volume":"123","author":"Koubeissi","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.seizure.2011.01.017","article-title":"Intravenous lacosamide \u2014 an effective add-on treatment of refractory status epilepticus","volume":"20","author":"Albers","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0135","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12028-010-9501-8","article-title":"The use of lacosamide in refractory status epilepticus","volume":"14","author":"Goodwin","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.eplepsyres.2010.12.014","article-title":"The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus","volume":"94","author":"Wasterlain","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.07.005_bb0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1528-1167.2012.03589.x","article-title":"The adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trials","volume":"54","author":"Zaccara","year":"2013","journal-title":"Epilepsia"}],"updated-by":[{"DOI":"10.1016\/j.yebeh.2020.107367","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000}}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017304869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017304869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:24:19Z","timestamp":1761503059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505017304869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"alternative-id":["S1525505017304869"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.07.005","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}